Angelman syndrome is a genetic disorder. It causes developmental disabilities, neurological problems and sometimes, seizures.
People with Angelman syndrome often smile and laugh frequently, and have happy, excitable personalities.
Developmental delays, between about 6 and 12 months of age, are usually the first signs of Angelman syndrome. Seizures often begin between the ages of 2 and 3 years old.
People with Angelman syndrome tend to live a normal life span, but the disease cannot be cured. Treatment focuses on managing medical and developmental issues.
Feb. 07, 2017
- NINDS Angelman syndrome information page. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/angelman/angelman.htm. Accessed Nov. 7, 2016.
- National Library of Medicine. Angelman syndrome. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/angelman-syndrome. Accessed Nov. 7, 2016.
- Angelman syndrome diagnostic criteria. Angelman Syndrome Foundation. http://www.angelman.org/understanding-as/medical-info/diagnostic-criteria/. Accessed Nov. 7, 2016.
- Pagon RA, et al., eds. Angelman syndrome. In: GeneReviews. Seattle, Wash.: University of Seattle, Washington; 1993-2016. http://www.ncbi.nlm.nih.gov/books/NBK1116. Accessed Nov. 7, 2016.
- Bailus BJ, et al. The prospect of molecular therapy for Angelman syndrome and other monogenic neurologic disorders. BMC Neuroscience. 2014;15:76.
- Angelman syndrome diagnostic testing. Angelman Syndrome Foundation. https://www.angelman.org/what-is-as/medical-information/diagnostic-testing/. Accessed Nov. 13, 2016.
- Buiting K, et al. Angelman syndrome — Insights into a rare neurogenetic disorder. Nature. 2016;12:584.
- Patterson MC (expert opinion). Mayo Clinic, Rochester, Minn. Nov. 22, 2016.